|
ARHGAP21 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.537900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.790200E-02 |
| Normal-vs-Stage2 |
9.559600E-02 |
| Normal-vs-Stage3 |
2.274200E-01 |
| Normal-vs-Stage4 |
1.408650E-01 |
| Stage1-vs-Stage2 |
9.530600E-01 |
| Stage1-vs-Stage3 |
9.221800E-01 |
| Stage1-vs-Stage4 |
5.893400E-01 |
| Stage2-vs-Stage3 |
8.991000E-01 |
| Stage2-vs-Stage4 |
5.531600E-01 |
| Stage3-vs-Stage4 |
5.528600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.302270E-02 |
| Normal-vs-AfricanAmerican |
2.138200E-01 |
| Normal-vs-Asian |
5.155200E-01 |
| Caucasian-vs-AfricanAmerican |
5.342400E-01 |
| Caucasian-vs-Asian |
9.712800E-01 |
| AfricanAmerican-vs-Asian |
8.572600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.387600E-04 |
| Normal-vs-Female |
2.898600E-01 |
| Male-vs-Female |
7.629200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.886100E-02 |
| Normal-vs-Extreme_Weight |
1.599580E-03 |
| Normal-vs-Obese |
4.462400E-01 |
| Normal-vs-Extreme_Obese |
2.242300E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.301600E-01 |
| Normal_Weight-vs-Obese |
2.362400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.400600E-01 |
| Extreme_Weight-vs-Obese |
3.810300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.233000E-01 |
| Obese-vs-Extreme_Obese |
9.117800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.234400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.131200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.237400E-03 |
| Normal-vs-Age(81-100Yrs) |
6.960000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.853000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.524410E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.635200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.348480E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.200300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.079800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.436000E-02 |
| Normal-VS-Type2 PRCC |
7.862600E-03 |
| Normal-VS-KIRP CIMP |
4.086000E-01 |
| Normal-VS-Unclassified PRCC |
8.699400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.484000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.672200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.429400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.574500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.122250E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.965200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.323990E-03 |
| Normal-vs-N1 |
3.040600E-01 |
| Normal-vs-N2 |
6.479200E-01 |
| N0-vs-N1 |
2.019200E-01 |
| N0-vs-N2 |
6.156800E-01 |
| N1-vs-N2 |
9.183000E-01 |
|
|
